The aim of this manuscript is to discuss the use of some advances in immunotherapies for cancer from an ethical standpoint. The analysis will be restricted to the application of gene-editing technologies to adoptive T cell immunotherap
Genome editing technologies promise therapeutic advances for genetic diseases. We discuss the ethica...
We present an overview of clinical trials involving gene editing using clustered interspaced short p...
Recent early stage clinical trials evaluating the adoptive transfer of patient CD8+ T-cells re-direc...
The adoptive transfer of engineered T cells for the treatment of cancer, autoimmunity, and infectiou...
First-generation adoptive T-cell transfer (ACT) administering tumor-infiltrating lymphocytes (TILs),...
The site-specific modification of an existing gene is known as gene editing. A section of DNA must b...
First-generation adoptive T-cell transfer (ACT) administering tumor-infiltrating lymphocytes (TILs),...
There are many steps involved in the process of introducing CRISPR-Cas9 into the current health care...
T cells following genome editing and transformation might be detectable in peripheral blood and tumo...
The development of clustered regularly interspaced short palindromic repeats (CRISPR) has spurred a ...
Gene editing has been a topic of controversy since the late 1970’s, however as of 2015 the topic of ...
Immunotherapies are emerging as highly promising approaches for the treatment of cancer. In these ap...
The recent breakthrough discovery of the molecular genome editing tool CRISPR/CAS9 represents a comp...
Adoptive immunotherapy is an appealing approach to cancer treatment, with the potential for more pre...
<b><i>Summary</i></b>The broaden application of adoptive T-cell transfer has been constrained by the...
Genome editing technologies promise therapeutic advances for genetic diseases. We discuss the ethica...
We present an overview of clinical trials involving gene editing using clustered interspaced short p...
Recent early stage clinical trials evaluating the adoptive transfer of patient CD8+ T-cells re-direc...
The adoptive transfer of engineered T cells for the treatment of cancer, autoimmunity, and infectiou...
First-generation adoptive T-cell transfer (ACT) administering tumor-infiltrating lymphocytes (TILs),...
The site-specific modification of an existing gene is known as gene editing. A section of DNA must b...
First-generation adoptive T-cell transfer (ACT) administering tumor-infiltrating lymphocytes (TILs),...
There are many steps involved in the process of introducing CRISPR-Cas9 into the current health care...
T cells following genome editing and transformation might be detectable in peripheral blood and tumo...
The development of clustered regularly interspaced short palindromic repeats (CRISPR) has spurred a ...
Gene editing has been a topic of controversy since the late 1970’s, however as of 2015 the topic of ...
Immunotherapies are emerging as highly promising approaches for the treatment of cancer. In these ap...
The recent breakthrough discovery of the molecular genome editing tool CRISPR/CAS9 represents a comp...
Adoptive immunotherapy is an appealing approach to cancer treatment, with the potential for more pre...
<b><i>Summary</i></b>The broaden application of adoptive T-cell transfer has been constrained by the...
Genome editing technologies promise therapeutic advances for genetic diseases. We discuss the ethica...
We present an overview of clinical trials involving gene editing using clustered interspaced short p...
Recent early stage clinical trials evaluating the adoptive transfer of patient CD8+ T-cells re-direc...
DOI
Add to ORKG